These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3099482)

  • 21. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T; Ozawa Y; Nakayama T; Matsuura H; Hashiguchi R; Matsuo N; Muto H; Yamazaki J; Morishita T; Saito T
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of tetrandrine on pulmonary hypertension in patients with chronic obstructive pulmonary disease].
    Kang J
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(2):93-4, 124. PubMed ID: 8221961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of a combination of sublingually administered vasodilating drugs for rapid action on pulmonary hypertension in patients with cardiac asthma and with pulmonary oedema.
    Daskalov TR
    Cor Vasa; 1987; 29(3):222-31. PubMed ID: 3113825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Precapillary pulmonary hypertension: effect of Captopril].
    Sanguinetti M; Galiè N; Magelli C; Orselli L; Magnani B
    G Ital Cardiol; 1982; 12(6):436-41. PubMed ID: 6761221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of pulmonary hypertension in potential candidates to heart transplantation.
    Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
    Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitroglycerin and isosorbide dinitrate in pulmonary hypertension of chronic obstructive pulmonary disease.
    Delaunois L; Jonard P; Kremer N; Dubois P; Lulling J
    Bull Eur Physiopathol Respir; 1984; 20(1):11-8. PubMed ID: 6423015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure.
    Roth A; Kulick D; Freidenberger L; Hong R; Rahimtoola SH; Elkayam U
    J Am Coll Cardiol; 1987 Apr; 9(4):858-64. PubMed ID: 3104435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical pulmonary vasoconstriction induced by nitroglycerin in idiopathic pulmonary hypertension.
    Hoit B; Gregoratos G; Shabetai R
    J Am Coll Cardiol; 1985 Aug; 6(2):490-2. PubMed ID: 3926849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute hemodynamic effects of nitroglycerin in pulmonary hypertension.
    Pearl RG; Rosenthal MH; Schroeder JS; Ashton JP
    Ann Intern Med; 1983 Jul; 99(1):9-13. PubMed ID: 6407380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of transdermal nitroglycerin patches in patients with acute myocardial infarction.
    Toman J; Lupinek Z; Janousek S; Nechvatal L; Zeman K
    Cardiology; 1991; 79 Suppl 2():58-62. PubMed ID: 1760832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reversible pulmonary arterial hypertension after medication of aminorexfumarate (author's transl)].
    Simon H; Felix R
    Med Klin; 1977 Oct; 72(41):1685-8. PubMed ID: 411019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nitroglycerin therapy in the management of pulmonary hypertensive disorders.
    Packer M; Halperin JL; Brooks KM; Rothlauf EB; Lee WH
    Am J Med; 1984 Jun; 76(6A):67-75. PubMed ID: 6430080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of ligustrazine and nitroglycerine on acute hypoxic pulmonary hypertension in anesthetized dogs].
    Cao W; Luo W; Guo Z
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Apr; 16(2):79-83. PubMed ID: 7987946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of nitrates on the peripheral arterial vascular system].
    Podhaisky H; Hänsgen K; Bartlitz C
    Z Gesamte Inn Med; 1987 Feb; 42(3):79-81. PubMed ID: 2954307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute nonhemodynamic pulmonary edema with nifedipine in primary pulmonary hypertension.
    Prigogine T; Waterlot Y; Gottignies P; Verhoeven A; Decroly P
    Chest; 1991 Aug; 100(2):563-4. PubMed ID: 1864141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of short-term and prolonged-action nitrates on the hemodynamic indices of patients with high-altitude pulmonary hypertension].
    Nanaeva MT; Nusupova DT
    Farmakol Toksikol; 1986; 49(5):84-6. PubMed ID: 2945738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Potential of proteinase-activated receptors as a novel target for treatment of pulmonary hypertension].
    Hirano K
    Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):182-6. PubMed ID: 24717606
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravenous nitroglycerin boluses in treating patients with cardiogenic pulmonary edema.
    Nashed AH; Allegra JR
    Am J Emerg Med; 1995 Sep; 13(5):612-3. PubMed ID: 7662071
    [No Abstract]   [Full Text] [Related]  

  • 40. Alpha blockade in pulmonary hypertension.
    Cottrell AJ; Pearson DT; Hunter S
    Pediatr Cardiol; 1982; 2(1):89-90. PubMed ID: 6460991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.